• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

处方阿片类药物致死:探究医者缘何成为元凶。

Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

机构信息

Institute for Social Science Research, The University of Queensland, Indooroopilly, QLD, 4068, Australia.

School of Clinical Medicine, Rural Clinical School, The University of Queensland, Hervey Bay, QLD, 4655, Australia.

出版信息

Drug Saf. 2018 Nov;41(11):1023-1033. doi: 10.1007/s40264-018-0687-6.

DOI:10.1007/s40264-018-0687-6
PMID:29796831
Abstract

Prescription opioid use has increased rapidly in developed countries, as have fatalities and other related adverse events. This review examines the intrinsic characteristics of opioids, including their mechanisms of action and pharmacokinetic and pharmacodynamic properties, to determine how the use of a regonised pharmacological remedy for a medically confirmed ailment could result in an accidental fatality. Opioids trigger biological processes that inhibit their own therapeutic effect. Prolonged use of opioids can result in activation of pronociceptive systems, leading to opioid-induced hyperalgesia and tolerance, while opioid metabolites can antagonise the antinociceptive action of the parent drug, also leading to opioid-induced hyperalgesia and tolerance. Pain stimulates respiration and counteracts the respiratory depression effect of opioids. Analgesia from opioids leads to loss of this protective mechanism, leading to increased risk of death due to respiratory failure. Increased patient counseling during opioid prescribing and dispensing, and limiting prescription to short-term use in non-malignant pain, may decrease the adverse effects of opioids. The vast majority of patients who unintentionally experience serious adverse events from pharmaceutical opioids do not start out as drug seekers. Even opioid use within prescribing guidelines can place some patients at risk of death and may prevent patients from seeking help for prescription opioid dependence.

摘要

处方类阿片在发达国家的使用迅速增加,与之相关的死亡和其他不良事件也随之增加。本综述检查了阿片类药物的内在特征,包括其作用机制、药代动力学和药效学特性,以确定一种公认的用于治疗医学疾病的药理学方法如何导致意外死亡。阿片类药物引发的生物过程会抑制其自身的治疗效果。长期使用阿片类药物会导致促伤害系统的激活,导致阿片类药物引起的痛觉过敏和耐受,而阿片类药物的代谢物可以拮抗母体药物的镇痛作用,也会导致阿片类药物引起的痛觉过敏和耐受。疼痛会刺激呼吸,抵消阿片类药物的呼吸抑制作用。阿片类药物的镇痛作用会导致这种保护机制丧失,从而增加因呼吸衰竭导致死亡的风险。在开具阿片类药物处方和配药时增加患者咨询,并将处方限制在非恶性疼痛的短期使用,可能会减少阿片类药物的不良反应。绝大多数意外发生严重药物不良反应的患者并非一开始就寻求药物。即使按照处方指南使用阿片类药物,也会使一些患者面临死亡风险,并可能使患者无法寻求治疗处方类阿片依赖。

相似文献

1
Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.处方阿片类药物致死:探究医者缘何成为元凶。
Drug Saf. 2018 Nov;41(11):1023-1033. doi: 10.1007/s40264-018-0687-6.
2
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
3
[Development of opioid tolerance -- molecular mechanisms and clinical consequences].[阿片类药物耐受性的发展——分子机制及临床后果]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2003 Jan;38(1):14-26. doi: 10.1055/s-2003-36558.
4
[Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].[贝鲁特法国主宫医院阿片类镇痛药的处方模式]
Encephale. 2016 Dec;42(6):511-516. doi: 10.1016/j.encep.2016.05.010. Epub 2016 Oct 21.
5
Mechanisms of opioid-induced tolerance and hyperalgesia.阿片类药物引起耐受性和痛觉过敏的机制。
Pain Manag Nurs. 2007 Sep;8(3):113-21. doi: 10.1016/j.pmn.2007.02.004.
6
Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.慢性非癌性疼痛阿片类药物的合理、安全与有效处方:美国介入性疼痛医师协会(ASIPP)指南
Pain Physician. 2017 Feb;20(2S):S3-S92.
7
Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective.阿片类药物耐受性的发展:药代动力学/药效学视角
AAPS J. 2008 Dec;10(4):537-51. doi: 10.1208/s12248-008-9056-1. Epub 2008 Nov 7.
8
Pain treatment with opioids : achieving the minimal effective and the minimal interacting dose.阿片类药物的疼痛治疗:实现最小有效剂量和最小相互作用剂量。
Clin Drug Investig. 2009;29 Suppl 1:3-16. doi: 10.2165/0044011-200929001-00002.
9
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.美国介入性疼痛医师学会(ASIPP)慢性非癌痛阿片类药物处方责任指南:第一部分——证据评估。
Pain Physician. 2012 Jul;15(3 Suppl):S1-65.
10
Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain.人脑成像中的阿片类镇痛及其在理解慢性疼痛中阿片类药物使用方面的潜在相关性。
Neuropharmacology. 2014 Sep;84(100):123-30. doi: 10.1016/j.neuropharm.2013.06.035. Epub 2013 Jul 25.

引用本文的文献

1
The contribution of pain catastrophizing, depression and anxiety symptoms among patients with persistent pain and opioid misuse behaviours.持续性疼痛和阿片类药物滥用行为患者中疼痛灾难化、抑郁和焦虑症状的作用。
J Behav Med. 2024 Apr;47(2):342-347. doi: 10.1007/s10865-023-00452-4. Epub 2023 Oct 7.
2
Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years.澳大利亚昆士兰州按剂量、剂型和社会经济地位使用的药物类阿片:22 年的人群研究。
Int J Clin Pharm. 2021 Apr;43(2):328-339. doi: 10.1007/s11096-020-01155-5. Epub 2020 Sep 23.
3
Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland, Australia.

本文引用的文献

1
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.阿片类药物与非阿片类药物对慢性背痛或髋部或膝部骨关节炎疼痛患者疼痛相关功能的影响:SPACE随机临床试验
JAMA. 2018 Mar 6;319(9):872-882. doi: 10.1001/jama.2018.0899.
2
Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose.规定剂量的阿片类药物与过量用药:非故意处方类阿片类药物过量的系统性回顾和荟萃分析。
CNS Drugs. 2018 Feb;32(2):101-116. doi: 10.1007/s40263-018-0499-3.
3
Additive Effects of Cointoxicants in Single-Opioid Induced Deaths.
阿片类药物使用时间与社会经济地位、日剂量和剂型的关系:澳大利亚昆士兰州一项为期 20 年的人群研究。
Int J Clin Pharm. 2021 Apr;43(2):340-350. doi: 10.1007/s11096-020-01079-0. Epub 2020 Jun 16.
单一阿片类药物所致死亡中合并使用其他毒物的叠加效应
Acad Forensic Pathol. 2016 Sep;6(3):532-542. doi: 10.23907/2016.053.
4
Opioid-induced hyperalgesia: Cellular and molecular mechanisms.阿片类药物诱导的痛觉过敏:细胞和分子机制。
Neuroscience. 2016 Dec 3;338:160-182. doi: 10.1016/j.neuroscience.2016.06.029. Epub 2016 Jun 23.
5
Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies.慢性疼痛中的阿片类药物滥用——误解与缓解策略
N Engl J Med. 2016 Mar 31;374(13):1253-63. doi: 10.1056/NEJMra1507771.
6
CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464.
7
Dopamine neurons share common response function for reward prediction error.多巴胺能神经元对奖励预测误差具有共同的反应功能。
Nat Neurosci. 2016 Mar;19(3):479-86. doi: 10.1038/nn.4239. Epub 2016 Feb 8.
8
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.非医疗处方阿片类药物使用与海洛因使用之间的关系。
N Engl J Med. 2016 Jan 14;374(2):154-63. doi: 10.1056/NEJMra1508490.
9
Chronic Pain Management: An Overview of Taxonomy, Conditions Commonly Encountered, and Assessment.慢性疼痛管理:分类法、常见病症及评估概述
Med Clin North Am. 2016 Jan;100(1):1-16. doi: 10.1016/j.mcna.2015.09.005. Epub 2015 Oct 28.
10
Mesolimbic dopamine signals the value of work.中脑边缘多巴胺传递工作的价值。
Nat Neurosci. 2016 Jan;19(1):117-26. doi: 10.1038/nn.4173. Epub 2015 Nov 23.